簡介

本頁面提供了有關 Stanley Hostler 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。
報告內部持倉的公司

SEC文件顯示Stanley Hostler已報告在以下公司擁有持倉或進行了交易：

證券 職位 最新報告的持倉
US:PRGB / Protea Biosciences Group Inc Secretary, Director, 10% Owner 22,299,859
如何解讀這些圖表

以下圖表顯示了在Stanley Hostler進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Stanley Hostler 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化		 每股
股價		 交易
金額		 剩餘
金額
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Class A Warrant (right to buy) 		J - Other 3,333,333 22,299,859 17.57
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Class B Warrant (right to buy) 		J - Other 3,333,333 22,299,859 17.57
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Class A Warrant (right to buy) 		J - Other 6,000,000 22,299,859 36.81
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Class B Warrant (right to buy) 		J - Other 6,000,000 22,299,859 36.81
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		J - Other 3,333,333 15,761,027 26.82
2017-04-04 2017-03-24 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		J - Other 6,000,000 15,761,027 61.47
2016-11-07 2016-11-03 4 PRGB Protea Biosciences Group, Inc.
Class A Warrant to Purchase Common Stock 		A - Award 293,333 293,333 0.08 22,000 22,000
2016-11-07 2016-11-03 4 PRGB Protea Biosciences Group, Inc.
Class B Warrant to Purchase Common Stock 		A - Award 293,333 293,333 0.08 22,000 22,000
2016-11-07 2016-11-03 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 293,333 2,724,992 12.06 0.08 22,000 204,374
2016-10-05 2016-09-20 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 50,000 2,431,659 2.10 0.10 4,945 240,491
2016-02-03 2015-12-31 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		G - Gift -100,000 2,381,659 -4.03
2016-02-03 2015-12-18 4 PRGB Protea Biosciences Group, Inc.
Director Stock Option (right to buy) 		A - Award 66,667 66,667
2016-02-03 2015-12-18 4 PRGB Protea Biosciences Group, Inc.
Common Stock 		A - Award 100,000 3,702,702 2.78
2014-02-13 2014-01-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,036,610 0.10 2,200.00 8,800,000 8,880,542,000
2014-02-13 2013-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,032,610 0.10 2,200.00 8,800,000 8,871,742,000
2014-02-13 2013-11-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,028,610 0.10 2,200.00 8,800,000 8,862,942,000
2014-02-13 2013-10-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,024,610 0.10 2,200.00 8,800,000 8,854,142,000
2014-02-13 2013-09-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,020,610 0.10 2,200.00 8,800,000 8,845,342,000
2014-02-13 2013-08-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,016,610 0.10 2,200.00 8,800,000 8,836,542,000
2014-02-13 2013-07-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,012,610 0.10 2,200.00 8,800,000 8,827,742,000
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		C - Conversion -1,137,896 4,008,610 -22.11 568,948.00 -647,403,653,408 2,280,690,642,280
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		C - Conversion -1,137,896 4,008,610 -22.11 568,948.00 -647,403,653,408 2,280,690,642,280
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		C - Conversion -14,831 5,058,610 -0.29 74,156.00 -1,099,807,636 375,126,283,160
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		C - Conversion -1,748,938 5,195,042 -25.19 874,469.00 -1,529,392,063,922 4,542,903,182,698
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 853,422 6,765,042 14.44 938,764.00 801,161,850,408 6,350,777,888,088
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 853,422 6,765,042 14.44 938,764.00 801,161,850,408 6,350,777,888,088
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 111,234 5,911,620 1.92 122,357.00 13,610,258,538 723,328,088,340
2014-02-13 2013-07-23 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 1,311,704 5,800,386 29.22 1,442,874.00 1,892,623,597,296 8,369,226,149,364
2014-02-13 2013-06-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,488,682 0.09 2,200.00 8,800,000 9,875,100,400
2014-02-13 2013-05-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,484,682 0.09 2,200.00 8,800,000 9,866,300,400
2014-02-13 2013-04-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,480,682 0.09 2,200.00 8,800,000 9,857,500,400
2014-02-13 2013-03-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,476,682 0.09 2,200.00 8,800,000 9,848,700,400
2014-02-13 2013-03-22 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 218,750 4,472,682 5.14 120,313.00 26,318,468,750 538,121,789,466
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 105,638 3,049,215 3.59 1.00 105,638 3,049,215
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 105,638 3,049,215 3.59 1.00 105,638 3,049,215
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 105,638 3,049,215 3.59 1.00 105,638 3,049,215
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 163,923 2,943,577 5.90 1.00 163,923 2,943,577
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 163,923 2,943,577 5.90 1.00 163,923 2,943,577
2014-02-13 2013-04-12 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 163,923 2,943,577 5.90 1.00 163,923 2,943,577
2014-02-13 2013-02-28 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,253,932 0.09 2,200.00 8,800,000 9,358,650,400
2014-02-13 2013-01-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,249,932 0.09 2,200.00 8,800,000 9,349,850,400
2014-02-13 2012-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 4,000 4,245,932 0.09 2,200.00 8,800,000 9,341,050,400
2014-02-13 2012-11-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 44,000 4,241,932 1.05 88,000.00 3,872,000,000 373,290,016,000
2014-02-13 2012-11-30 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 550,000 4,197,932 15.08 275,000.00 151,250,000,000 1,154,431,300,000
2014-02-13 2012-11-30 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 550,000 4,197,932 15.08 275,000.00 151,250,000,000 1,154,431,300,000
2014-02-13 2012-11-30 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 650,000 3,647,932 21.68 325,000.00 211,250,000,000 1,185,577,900,000
2014-02-13 2012-09-25 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 136,432 2,997,932 4.77 68,216.00 9,306,845,312 204,506,929,312
2014-02-13 2012-09-25 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 300,000 2,861,500 11.71 150,000.00 45,000,000,000 429,225,000,000
2014-02-13 2012-09-25 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 300,000 2,861,500 11.71 150,000.00 45,000,000,000 429,225,000,000
2014-02-13 2012-09-25 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 140,000 2,561,500 5.78 70,000.00 9,800,000,000 179,305,000,000
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 25,000 2,421,500 1.04 56,250.00 1,406,250,000 136,209,375,000
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 25,000 2,421,500 1.04 56,250.00 1,406,250,000 136,209,375,000
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 12,500 2,396,500 0.52 28,125.00 351,562,500 67,401,562,500
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 50,000 2,510,093 2.03 2.00 100,000 5,020,186
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 50,000 2,510,093 2.03 2.00 100,000 5,020,186
2014-02-13 2012-07-27 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 25,000 2,460,093 1.03 2.00 50,000 4,920,186
2014-02-13 2012-04-16 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 200,000 2,384,000 9.16 100,000.00 20,000,000,000 238,400,000,000
2014-02-13 2012-04-16 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 200,000 2,384,000 9.16 100,000.00 20,000,000,000 238,400,000,000
2014-02-13 2012-04-16 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 280,000 2,184,000 14.71 140,000.00 39,200,000,000 305,760,000,000
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 28,766 2,435,093 1.20 1.50 43,149 3,652,640
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 28,766 2,435,093 1.20 1.50 43,149 3,652,640
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 28,766 2,435,093 1.20 1.50 43,149 3,652,640
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 83,360 2,406,327 3.59 1.50 125,040 3,609,490
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 83,360 2,406,327 3.59 1.50 125,040 3,609,490
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 83,360 2,406,327 3.59 1.50 125,040 3,609,490
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 135,621 2,322,967 6.20 1.50 203,432 3,484,450
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 135,621 2,322,967 6.20 1.50 203,432 3,484,450
2014-02-13 2012-03-01 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 135,621 2,322,967 6.20 1.50 203,432 3,484,450
2014-02-13 2011-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 12,000 1,904,000 0.63 24,000.00 288,000,000 45,696,000,000
2014-02-13 2011-12-27 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 25,000 1,392,000 1.83 56,250.00 1,406,250,000 78,300,000,000
2014-02-13 2011-12-27 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 25,000 1,392,000 1.83 56,250.00 1,406,250,000 78,300,000,000
2014-02-13 2011-12-27 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 50,000 1,939,599 2.65 2.00 100,000 3,879,198
2014-02-13 2011-12-27 4 NONE Protea Biosciences Group, Inc.
Common Stock 		P - Purchase 50,000 1,939,599 2.65 2.00 100,000 3,879,198
2014-02-13 2011-12-20 4 NONE Protea Biosciences Group, Inc.
Convertible Note 		P - Purchase 500,000 1,892,000 35.92 250,000.00 125,000,000,000 473,000,000,000
2014-02-13 2011-09-30 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 36,000 1,367,000 2.70 54,000.00 1,944,000,000 73,818,000,000
2014-02-13 2011-08-31 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 16,000 1,331,000 1.22 32,000.00 512,000,000 42,592,000,000
2014-02-13 2011-05-31 4 NONE Protea Biosciences Group, Inc.
Warrant 		P - Purchase 50,000 1,315,000 3.95 100,000.00 5,000,000,000 131,500,000,000
2014-02-13 2010-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 48,000 1,265,000 3.94 72,000.00 3,456,000,000 91,080,000,000
2014-02-13 2010-09-17 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 100,000 1,217,000 8.95 150,000.00 15,000,000,000 182,550,000,000
2014-02-13 2009-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 48,000 1,117,000 4.49 72,000.00 3,456,000,000 80,424,000,000
2014-02-13 2008-12-31 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 48,000 1,069,000 4.70 72,000.00 3,456,000,000 76,968,000,000
2014-02-13 2007-09-01 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 16,000 1,021,000 1.59 24,000.00 384,000,000 24,504,000,000
2014-02-13 2006-06-07 4 NONE Protea Biosciences Group, Inc.
Stock Option 		A - Award 100,000 1,005,000 11.05 80,000.00 8,000,000,000 80,400,000,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券（例如期權）
V
內部人士透過Form 4自願報告的一筆交易
J
其他（附有交易描述的腳註）